Nanovery
Nanovery is a biotechnology company developing Nucleic Acid Nanorobotics (NANs) for direct, enzyme-free quantification of siRNA, ASO, and other RNA therapeutics. Our DNA nanotechnology enables sensitive, fast, and extraction-free bioanalysis in complex biological matrices, supporting pharmacokinetic studies from early discovery through preclinical development. Nanovery works with leading innovators worldwide to accelerate RNAi drug development.
